Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

NCT01266993

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Draguignan, France
  • GSK Investigational Site Le Havre, France
  • GSK Investigational Site Lingolsheim, France
  • GSK Investigational Site Miribel, France
View all 24 locations
View Trial Details
Completed

A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

NCT02531698

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Helsinki South Vaccine Research Clinic Helsinki, Finland
  • Oulu Vaccine Research Clinic Oulu, Finland
  • Pori Vaccine Research Clinic Pori, Finland
View all 15 locations
View Trial Details
Completed

A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)

NCT02451514

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Santiago, Chile
  • GSK Investigational Site Bogotá, Colombia
  • GSK Investigational Site Bogotá, Colombia
  • GSK Investigational Site Panama City, Panama
View Trial Details
Completed

Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose

NCT01543087

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC Chandler, Arizona, United States
  • Clinical Research Advantage, Inc./ East Valley Family Physicians, PLC Chandler, Arizona, United States
  • St. Joseph Heritage Healthcare Huntington Beach, California, United States
  • Center For Clinical Trials, LLC Paramount, California, United States
View all 56 locations
View Trial Details

Related conditions